Generally, the DNA methylation pattern of the CD147/BSG gene promoter was low and not variable in tumor tissue, underpinning a minor impact of DNA methylation on variability of expression in ccRCC. This evidence concerns the gene BSG and nonpapillary renal cell carcinoma.